More articles from Asthma and COPD

Reducing carbon footprint by switching to reusable soft-mist inhalers
Christer Janson, Jaime Hernando Platz, Stéphane Soulard, Sue Langham, Lindsay Nicholson, Elisabeth Sophia Hartgers-Gubbels

ERJ Open Research May 2023, 9 (3) 00543-2022; DOI: 10.1183/23120541.00543-2022
Artificial intelligence based software facilitates spirometry quality control in asthma and COPD clinical trials
Eva Topole, Sonia Biondaro, Isabella Montagna, Sandrine Corre, Massimo Corradi, Sanja Stanojevic, Brian Graham, Nilakash Das, Kevin Ray, Marko Topalovic

ERJ Open Research Jan 2023, 9 (1) 00292-2022; DOI: 10.1183/23120541.00292-2022
Treatment with interleukin (IL)-5/IL-5 receptor antibodies in patients with severe eosinophilic asthma and COPD
Nora Drick, Jan Fuge, Benjamin Seeliger, Milan Speth, Jens Vogel-Claussen, Tobias Welte, Hendrik Suhling

ERJ Open Research Oct 2022, 8 (4) 00207-2022; DOI: 10.1183/23120541.00207-2022
Validation of a diagnosis-agnostic symptom questionnaire for asthma and/or COPD
Niklas Karlsson, Mark J. Atkinson, Hana Müllerová, Marianna Alacqua, Christina Keen, Rod Hughes, Christer Janson, Barry Make, David Price, Helen K. Reddel, NOVELTY study investigators

ERJ Open Research Jan 2021, 7 (1) 00828-2020; DOI: 10.1183/23120541.00828-2020
Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies
Rupert Jones, Andy Nicholls, Dominy Browning, Nawar Diar Bakerly, Ashley Woodcock, Jørgen Vestbo, David A. Leather, Loretta Jacques, James Lay-Flurrie, Henrik Svedsater, Susan Collier

ERJ Open Research Jan 2020, 6 (1) 00193-2019; DOI: 10.1183/23120541.00193-2019

Main menu

User menu

Search

More articles from Asthma and COPD

Contact us